Study of Safety of Foradil in Patients With Persistent Asthma

Stopped early · Phase 4 · Has a placebo group

Conditions studied: Persistent Asthma

In brief

The purpose of this study was to assess whether the risk of serious asthma-related events (asthma-related hospitalizations, asthma related intubations, and asthma related deaths) in adolescents and adults (12 years of age and older) taking inhaled formoterol fumarate/fluticasone propionate combination was the same as those taking inhaled fluticasone propionate alone.

Key facts

Study ID
NCT01845025
Run by
Novartis Pharmaceuticals
People needed
827
Starts
2013-05-01
Expected to finish
2016-05-01
Last updated by the study team
2017-03-21

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.